Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05938010 · ClinicalTrials.gov registry record
Subjective Wearing Experience of the Total30 for Astigmatism Lens Among Satisfied Biofinity Toric Lens Wearers
A clinical trial, sponsored by Scripps Poway Eyecare and Optometry.
- Completed
- Registry status
- 42
- Enrollment target
NCT05938010 is a clinical trial that has completed, run by Scripps Poway Eyecare and Optometry. The registered enrollment target is 42 participants.
The verdict
NCT05938010 has completed, sponsored by Scripps Poway Eyecare and Optometry.
- COMPLETED
- Registry status
- 42 participants
- Enrollment target
Study Summary
To subjectively evaluate wearing experience in the T30fA lens among subjects who were already satisfied with their Biofinity Toric lenses.
Interventions
- DEVICE Dailies Total1® contact lenses for astigmatism (T30fA)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 42 participants |
| Start Date | 2023-07-25 |
| Est. Completion | 2023-09-26 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05938010
The ClinicalTrials.gov registry entry for NCT05938010 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 42 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Scripps Poway Eyecare and Optometry, which has 4 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Dailies Total1® contact lenses for astigmatism (T30fA) is the first listed.
NCT05938010 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05938010 about?
NCT05938010 is a clinical study titled "Subjective Wearing Experience of the Total30 for Astigmatism Lens Among Satisfied Biofinity Toric Lens Wearers". To subjectively evaluate wearing experience in the T30fA lens among subjects who were already satisfied with their Biofinity Toric lenses.
What is the current status of trial NCT05938010?
This trial is currently completed. The enrollment target is 42 participants. The study started on 2023-07-25. Estimated completion is 2023-09-26.
What interventions are being tested in trial NCT05938010?
The interventions under investigation include: Dailies Total1® contact lenses for astigmatism (T30fA) (DEVICE).
Who is sponsoring clinical trial NCT05938010?
This trial is sponsored by Scripps Poway Eyecare and Optometry, which has 4 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.